InsidersTradesSigma
Browse the full insider trade history of Caris Life Sciences, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was disclosed on 2 June 2026 (Attribution). Among the most active insiders: POSTE GEORGE. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
3 of 3 declarations